Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherPractice

Answer: Can you identify this condition?

Salvador Arias-Santiago, María Sierra Girón-Prieto, Husein Husein-El-Ahmed, María Antonia Fernández-Pugnaire and Ramón Naranjo-Sintes
Canadian Family Physician December 2010; 56 (12) 1304-1306;
Salvador Arias-Santiago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Sierra Girón-Prieto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Husein Husein-El-Ahmed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Antonia Fernández-Pugnaire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramón Naranjo-Sintes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Answer to Dermacase continued from page 1303

4. Genital herpes

Genital herpes is a common, highly infectious disease caused by the herpes simplex virus (HSV). It is transmitted from one person to another by close personal contact, such as during sexual activity. There are 2 types of herpes: HSV-1 and HSV-2. The genital sores caused by either virus look the same. Most genital herpes infections are caused by HSV-2, and risk of infection is correlated with the number of lifetime sexual partners. Less often, HSV-1 can cause genital herpes infections through oral sexual contact. Up to 80% of HSV infections are asymptomatic. Symptomatic infections can be characterized by increased rates of morbidity and recurrence; in immunocompromised patients, infections can cause life-threatening complications.1

Description

The average incubation period after genital acquisition of HSV-1 or HSV-2 is approximately 4 days. Primary infection of genital herpes in men is characterized by a pattern of erosive balanitis, producing substantial pain; vesicles appear in the prepuce, the shaft of the penis, and sometimes on the scrotum. The perianal area and rectum might also be involved. Herpetic urethritis occurs in 35% to 45% of affected men and is characterized by severe dysuria and mucoid discharge. In women, herpetic vesicles can appear on the external genitalia (ie, labia majora, labia minora, or vaginal vestibule), and the cervix is involved in a high percentage of cases characterized by ulcerative or necrotic cervical mucosa. The ulcerative lesions persist for 4 to 15 days until crusting and re-epithelialization occur. Fever and locoregional lymphadenopathy distinguish greater local involvement from successive relapses. Most morbidity associated with genital herpes is due to its frequent reactivation rate, which is more common in HSV-2 and in patients who have had severe primary genital herpes. Recurrent genital herpes presents as 1 or more patches of grouped vesicles on the genitals and fever; constitutional symptoms are uncommon, pain is mild, and lesions heal in 7 to 10 days. The frequency and severity of recurrences decrease with time.2

Central nervous system complications of genital herpes include aseptic meningitis, sacral radiculopathy, transverse myelitis, and benign recurrent lymphocytic meningitis.

Diagnosis

When the medical history is incomplete, the lesions are atypical, or a quick diagnosis is needed because the patient is immunocompromised, has severe or disseminate disease, or has incurred serious repercussions from a previous incorrect diagnosis or treatment, additional tests should be ordered to confirm the diagnosis of herpesvirus (Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Laboratory tests available for the diagnosis of herpesvirus infections

In patients with HSV, histology will reveal intraepidermal blistering caused by keratinocyte necrosis and grayish nuclear inclusions with a ground-glass appearance, together with chromatin margination. Multinucleated giant cells and epithelial cells containing eosinophilic intranuclear inclusion bodies can be identified with the Tzanck test. Neither test is useful in differentiating between lesions caused by HSV-1 and those caused by HSV-2. Blood tests (ie, antibody tests) are only useful in the diagnosis of primary, but not recurrent, herpes infections. In the present case, the patient was positive for HSV-2 immunoglobulin M, confirming the diagnosis of primary infection.

The criterion standard for diagnosis of an HSV infection is the isolation of the virus in tissue culture; this method can yield positive results within 48 hours of inoculation. Characteristic cytopathic effects, with ballooning of cells and cell death, are observed; immunofluorescent staining of the tissue culture cells can quickly identify HSV and can help distinguish between types 1 and 2. Viral antigen detection by direct immunofluorescence of a specimen from a fresh vesicular lesion is an economical, rapid, and sensitive diagnostic tool. Other tests examine viral genetic material using in situ hybridization or polymerase chain reaction. These tests are quick and sensitive but rarely necessary in routine practice.

The differential diagnosis for genital herpes includes syphilis, candidiasis, herpes zoster, hand-foot-and-mouth disease, chancroid, and granuloma inguinale. Primary syphilis is characterized by one or more painless, indurated ulcers occurring at the site of inoculation; chancroid ulcerations, caused by Hemophilus ducreyi, are typically painful, tender, nonindurated lesions covered with gray or yellow necrotic purulent exudates. Noninfectious conditions that can mimic genital herpes include Reiter syndrome, contact dermatitis, Crohn disease, Behçet syndrome, trauma, erythema multiforme, and lichen planus.

Management

Treatment of HSV infection is centred on specific antiviral treatment. Although the same medications are active against both HSV-1 and HSV-2 infections, the location of the lesions and the chronicity of the infection (ie, primary or recurrent) dictate dosage and frequency. For initial treatment, 200 mg of oral acyclovir should be taken 5 times daily for 5 to 10 days, which should reduce the duration of viral shedding, time to crusting, and time to healing.3 In the present case, treatment with oral acyclovir for 5 days resolved the pain and the lesions.

For life-threatening HSV infections in immunocompromised patients or in patients with neurologic complications, intravenous acyclovir administered 3 times daily should be considered. Also, its derivatives—famciclovir (250 mg, 3 times daily for 5 to 10 days), penciclovir (1 topical application every 2 to 4 hours per day for 4 days), or valacyclovir (1000 mg, twice daily for 10 days)—have been shown to be safe and effective in the treatment of active disease. Acyclovir, valacyclovir, and famciclovir are all effective for the treatment or long-term suppression of recurrent episodes of genital herpes. However, topical acyclovir provides no benefit in the episodic treatment of genital herpes and is not recommended. If episodic therapy is used, it should be started at the first sign of recurrence, including during the prodromal period (if it is recognized). Several drugs, such as foscarnet, cidofovir, or trifluridine, can be used for the treatment of acyclovir-resistant cases of HSV.

Some approaches to preventing the transmission of HSV to uninfected persons are the use of condoms and antiviral suppressive therapy in the seropositive partner; however, the risk of transmission is not completely eliminated.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Kimberlin DW,
    2. Rouse DJ
    . Clinical practice. Genital herpes. N Engl J Med 2004;350(19):1970-7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Benedetti JK,
    2. Zeh J,
    3. Corey L
    . Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131(1):14-20.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Leung DT,
    2. Sacks SL
    . Current recommendations for the treatment of genital herpes. Drugs 2000;60(6):1329-52.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 56 (12)
Canadian Family Physician
Vol. 56, Issue 12
1 Dec 2010
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Answer: Can you identify this condition?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Answer: Can you identify this condition?
Salvador Arias-Santiago, María Sierra Girón-Prieto, Husein Husein-El-Ahmed, María Antonia Fernández-Pugnaire, Ramón Naranjo-Sintes
Canadian Family Physician Dec 2010, 56 (12) 1304-1306;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Answer: Can you identify this condition?
Salvador Arias-Santiago, María Sierra Girón-Prieto, Husein Husein-El-Ahmed, María Antonia Fernández-Pugnaire, Ramón Naranjo-Sintes
Canadian Family Physician Dec 2010, 56 (12) 1304-1306;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • 4. Genital herpes
    • Description
    • Diagnosis
    • Management
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Question: Can you identify this condition?
  • Question: Can you identify this condition?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
  • Managing type 2 diabetes in primary care during COVID-19
Show more Practice

Dermacase

  • Question: Can you identify this condition?
  • Answer: Can you identify this condition?
  • Question: Can you identify this condition?
Show more Dermacase

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire